SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $748 | -70.6% | 24,900 | -64.5% | 0.00% | -25.0% |
Q1 2023 | $2,541 | +8975.0% | 70,200 | +8675.0% | 0.00% | – |
Q4 2022 | $28 | -99.9% | 800 | 0.0% | 0.00% | – |
Q3 2022 | $27,000 | -99.5% | 800 | -99.6% | 0.00% | -100.0% |
Q3 2019 | $4,946,000 | +66.1% | 180,000 | +100.0% | 0.01% | -15.4% |
Q2 2019 | $2,978,000 | -5.6% | 90,000 | 0.0% | 0.01% | -7.1% |
Q1 2019 | $3,153,000 | +23.3% | 90,000 | +16.9% | 0.01% | +7.7% |
Q4 2018 | $2,557,000 | -36.3% | 77,000 | -3.5% | 0.01% | -27.8% |
Q3 2018 | $4,017,000 | -17.4% | 79,800 | -1.8% | 0.02% | -14.3% |
Q2 2018 | $4,865,000 | -13.3% | 81,300 | -33.6% | 0.02% | -16.0% |
Q1 2018 | $5,610,000 | +9.3% | 122,500 | -4.9% | 0.02% | +13.6% |
Q4 2017 | $5,132,000 | +8.0% | 128,800 | +8.4% | 0.02% | +10.0% |
Q3 2017 | $4,752,000 | -9.5% | 118,800 | -2.5% | 0.02% | -13.0% |
Q2 2017 | $5,249,000 | +0.6% | 121,800 | -26.9% | 0.02% | 0.0% |
Q1 2017 | $5,217,000 | -1.4% | 166,700 | -20.5% | 0.02% | 0.0% |
Q4 2016 | $5,291,000 | -2.5% | 209,570 | -4.6% | 0.02% | -4.2% |
Q3 2016 | $5,429,000 | +6.8% | 219,570 | -12.0% | 0.02% | +4.3% |
Q2 2016 | $5,083,000 | +13.5% | 249,570 | -15.0% | 0.02% | +21.1% |
Q1 2016 | $4,478,000 | +17.5% | 293,640 | +3.5% | 0.02% | +11.8% |
Q4 2015 | $3,812,000 | +51.5% | 283,640 | +58.1% | 0.02% | +41.7% |
Q3 2015 | $2,516,000 | +686.2% | 179,400 | +849.2% | 0.01% | +1100.0% |
Q2 2015 | $320,000 | – | 18,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
S&T BANK/PA | 223,775 | $8,107 | 1.46% |
Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |